A photo of Christine Phillips.

Director, CAR T and Immunotherapy

Associate Professor, UC Department of Pediatrics



Board Certified

My Biography & Research


Christine Phillips, MD, is an oncologist with a clinical focus on leukemia and lymphoma and a clinical and translational research focus on the development of novel therapies for pediatric leukemia and in leukemia pharmacogenetics.

Dr. Phillips earned her undergraduate degree in biochemistry and her medical degree from Indiana University, completed her residency in pediatrics at Children’s Memorial Hospital in Chicago, and her fellowship in pediatric hematology/oncology at Cincinnati Children’s, where she was co-chief fellow. She was a 2008 Hyundai Hope on Wheels Foundation Scholar.

Academic Affiliation

Associate Professor, UC Department of Pediatrics

Clinical Divisions

Cancer and Blood Diseases, Leukemia, Fertility Preservation

Research Divisions


Blog Posts

4 Must-Know Points About CAR T-Cell Therapy

BlogCancer and Blood Diseases

4 Must-Know Points About CAR T-Cell Therapy

By Christine Phillips, MD10/10/2017

My Locations

My Education

MD: Indiana University School of Medicine, Indianapolis, IN, 2002.

Residency: Pediatrics, Children’s Memorial Hospital, Chicago, IL, 2005.

Fellowship: Pediatric Hematology/Oncology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 2010.

Certification: Pediatrics, 2005; Pediatric Hematology/Oncology, 2011.

My Publications

Chimeric Antigen Receptor T Cell Therapy in Patients with Multiply Relapsed or Refractory Extramedullary Leukemia. Rubinstein, JD; Krupski, C; Nelson, AS; O'Brien, MM; Davies, SM; Phillips, CL. Biology of Blood and Marrow Transplantation. 2020; 26:e280-e285.

Genomic variants of cytarabine sensitivity associated with treatment-related mortality in pediatric AML: A report from the children's oncology group. Phillips, CL; Lane, A; Gerbing, RB; Alonzo, TA; Wilkey, A; Radloff, G; Lange, B; Gamazon, ER; Dolan, ME; Davies, SM. Clinical Cancer Research. 2020; 26:2891-2897.

Chimeric antigen receptor T-cell therapy in patients with neurologic comorbidities. Rubinstein, JD; Nelson, AS; Krupski, C; O'Brien, W; Taylor, JM; Badgett, TC; Huang, M; Davies, SM; Phillips, CL. Pediatric Blood and Cancer. 2020; 67.

Reducing minimal residual disease with blinatumomab prior to HCT for pediatric patients with acute lymphoblastic leukemia. Keating, AK; Gossai, N; Phillips, CL; Maloney, K; Campbell, K; Doan, A; Bhojwani, D; Burke, MJ; Verneris, MR. Blood Advances. 2019; 3:1926-1929.

Viral surveillance using PCR during treatment of AML and ALL. Dixon, SB; Lane, A; O'Brien, MM; Burns, KC; Mangino, JL; Breese, EH; Absalon, MJ; Perentesis, JP; Phillips, CL. Pediatric Blood and Cancer. 2018; 65:e26752-e26752.

Post-transplant lymphoproliferative disorder after solid-organ transplant in children. Absalon, MJ; Khoury, RA; Phillips, CL. Seminars in Pediatric Surgery. 2017; 26:257-266.